[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1949-2553&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00034803380004
© 2016 American Association for Cancer Research.The majority of patients with melanoma harbor mutati...
My PhD thesis has been directed to the study of the mechanisms responsible for the development of dr...
© 2020 Emily Jane LelliottThe recent advent of targeted and immune-based therapies has revolutionize...
BRAF inhibitors were approved for the treatment of BRAF-mutant melanoma. However, most patients acqu...
The advent of mitogen-activated protein kinase (MAPK) inhibitors that directly inhibit tumor growth ...
The prognosis of patients with metastatic melanoma is poor and not influenced by systemic therapy wi...
Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. ...
42 p.-7 fig.Melanoma treatment with the BRAF V600E inhibitor vemurafenib provides therapeutic benefi...
Fulltext embargoed for: 6 months post date of publicationThe BRAF mutant, BRAF(V600E), is expressed ...
Resistance to BRAF inhibitors is a major clinical problem. Here, we evaluate BI-847325, an ATP-compe...
Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors ...
inh ll l BRAF mutation, the MAPK pathway, and therefore the growth of melanoma cells, can be efficie...
Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors ...
The clinical development of selective BRAF inhibitors for metastatic BRAF V600 mutant melanoma patie...
V-RAF murine sarcoma viral oncogene homolog B1 (BRAF) is a serine/threonine-specific protein kinase ...
© 2016 American Association for Cancer Research.The majority of patients with melanoma harbor mutati...
My PhD thesis has been directed to the study of the mechanisms responsible for the development of dr...
© 2020 Emily Jane LelliottThe recent advent of targeted and immune-based therapies has revolutionize...
BRAF inhibitors were approved for the treatment of BRAF-mutant melanoma. However, most patients acqu...
The advent of mitogen-activated protein kinase (MAPK) inhibitors that directly inhibit tumor growth ...
The prognosis of patients with metastatic melanoma is poor and not influenced by systemic therapy wi...
Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. ...
42 p.-7 fig.Melanoma treatment with the BRAF V600E inhibitor vemurafenib provides therapeutic benefi...
Fulltext embargoed for: 6 months post date of publicationThe BRAF mutant, BRAF(V600E), is expressed ...
Resistance to BRAF inhibitors is a major clinical problem. Here, we evaluate BI-847325, an ATP-compe...
Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors ...
inh ll l BRAF mutation, the MAPK pathway, and therefore the growth of melanoma cells, can be efficie...
Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors ...
The clinical development of selective BRAF inhibitors for metastatic BRAF V600 mutant melanoma patie...
V-RAF murine sarcoma viral oncogene homolog B1 (BRAF) is a serine/threonine-specific protein kinase ...
© 2016 American Association for Cancer Research.The majority of patients with melanoma harbor mutati...
My PhD thesis has been directed to the study of the mechanisms responsible for the development of dr...
© 2020 Emily Jane LelliottThe recent advent of targeted and immune-based therapies has revolutionize...